Taiko Pharmaceutical Co (TSE:4574) Other Long-Term Liabilities : 円377 Mil (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Other Long-Term Liabilities?

Taiko Pharmaceutical Co's other long-term liabilities for the quarter that ended in Jun. 2024 was 円377 Mil.

Taiko Pharmaceutical Co's quarterly other long-term liabilities increased from Dec. 2023 (円242 Mil) to Mar. 2024 (円263 Mil) and increased from Mar. 2024 (円263 Mil) to Jun. 2024 (円377 Mil).

Taiko Pharmaceutical Co's annual other long-term liabilities increased from Mar. 2020 (円0 Mil) to Dec. 2021 (円242 Mil) and increased from Dec. 2021 (円242 Mil) to Dec. 2022 (円261 Mil).

Taiko Pharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Taiko Pharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Other Long-Term Liabilities Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Other Long-Term Liabilities

Get a 7-Day Free Trial

4.20

242.00

261.00

Taiko Pharmaceutical Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															209.00	242.00	242.00	263.00	377.00

Taiko Pharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Taiko Pharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co Headlines

No Headlines